# Safety and Immune Response of Different Pediatric Combination Vaccines.

> **NCT00255047** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 2167 (actual)

## Conditions studied

- Diphtheria
- Polio
- Pertussis

## Interventions

- **BIOLOGICAL:** DAPTACEL®. (DTaP), IPOL®., and ActHIB®.
- **BIOLOGICAL:** Pentacel®: DTaP-IPV/Hib combined
- **BIOLOGICAL:** DTaP-IPV and ActHIB®
- **BIOLOGICAL:** Pentacel®: DTaP-IPV/Hib combined

## Key facts

- **NCT ID:** NCT00255047
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-07
- **Final completion:** 2009-02
- **Target enrollment:** 2167 (ACTUAL)
- **Last updated:** 2014-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255047, "Safety and Immune Response of Different Pediatric Combination Vaccines.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00255047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*